Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus

Completed · Phase 3

Conditions studied: Cataract

In brief

The purpose of this study is to determine the safety and efficacy of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS Plus for use during cataract extraction and intra-ocular lens (IOL) implantation.

Key facts

Study ID

NCT00333268

Run by

Alcon Research

People needed

369

Starts

2004-09-01

Expected to finish

2005-07-01

Last updated by the study team

2012-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients any race or sex 18 or older and undergoing cataract extraction with planned implantation of a posterior chamber intraocular lens.
• Other protocol-defined inclusion criteria may apply.

You may not qualify if…

• Under 18
• Other protocol-defined exclusion criteria may apply.

Where it is running

• United States — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.